Hypofractionated stereotactic radiotherapy for the treatment of brain metastases
β Scribed by Alexander K. Kwon; Steven J. DiBiase; Brian Wang; Samuel L. Hughes; Barry Milcarek; Yunping Zhu
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 188 KB
- Volume
- 115
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND. Brain metastases are a frequent complication in advanced melanoma. A 3.6 to 4.1βmonth median survival has been reported after treatment with whole brain radiotherapy. We performed a retrospective analysis of our institutional experience of multimodality treatment utilizi
Results of a Single Institution Series ## BACKGROUND. Stereotactic radiosurgery is being used with increasing frequency John C. Breneman, M
Medical Center is the radiotherapy facility for the Children's Hospital of Pittsburgh. 2 Patient #7 was 21 years old when treated because of the 135-month latent period.
Surgical resection and whole brain radiotherapy (WBRT) have been the mainstays of the treatment of cerebral metastases. This approach results in a median survival of about 10 months. Several recent publications and our own experience suggest that a similar median survival can be achieved with stereo